Maruo H, Kosaka A
Dept. of Surgery, Shimizu City Hospital.
Gan To Kagaku Ryoho. 1993 Aug;20(11):1473-6.
Twenty-two patients with unresectable hepatocellular carcinoma were treated by intra-arterial infusion chemotherapy using an implantable reservoir. The catheter was placed in the hepatic artery via the left subclavian artery. Adriamycin or epirubicin were administered intermittently. From the result, the response rate in all cases was 22.7%, and no difference in the response rate by Stage was observed. However, the less the hepatic disturbance, the greater the effect was: 75% in clinical stage I, 18.2% in II and 0% in III. Significant differences of ICG R15, doses and frequency of intra-arterial infusion were observed between PR, NC and PD cases. The usefulness of this chemotherapy was suggested in highly advanced hepatocellular carcinoma, especially in Vp3.
22例无法切除的肝细胞癌患者采用植入式储液器进行动脉内灌注化疗。通过左锁骨下动脉将导管置于肝动脉。阿霉素或表柔比星间歇性给药。结果显示,所有病例的缓解率为22.7%,各分期的缓解率未见差异。然而,肝脏损害越小,效果越好:临床I期为75%,II期为18.2%,III期为0%。PR、NC和PD病例之间在ICG R15、动脉内灌注剂量和频率方面存在显著差异。该化疗方法在晚期肝细胞癌,尤其是Vp3期患者中显示出有效性。